null
Loading... Please wait...
FREE SHIPPING on All Unbranded Items LEARN MORE
Print This Page

An Analytic Assessment of U.S. Drug Policy

List Price: $20.00
SKU:
9780844741918
Quantity:
Minimum Purchase
25 unit(s)
  • Availability: Confirm prior to ordering
  • Branding: minimum 50 pieces (add’l costs below)
  • Check Freight Rates (branded products only)

Branding Options (v), Availability & Lead Times

  • 1-Color Imprint: $2.00 ea.
  • Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
  • Belly-Band Wrap: $2.50 ea. (full-color printed)
  • Set-Up Charge: $45 per decoration
FULL DETAILS
  • Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
  • Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
  • Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
  • RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
  • Product Details

    Author:
    David Boyum, Peter Reuter
    Format:
    Paperback
    Pages:
    133
    Publisher:
    AEI Press (December 1, 2005)
    Language:
    English
    Audience:
    Professional and scholarly
    ISBN-13:
    9780844741918
    ISBN-10:
    0844741914
    Weight:
    5.6oz
    Dimensions:
    6" x 9" x 0.6"
    Case Pack:
    56
    File:
    TWO RIVERS-PERSEUS-Perseus_Distribution_Customer_Group_Metadata_20260211195233-20260211.xml
    Folder:
    TWO RIVERS
    List Price:
    $20.00
    As low as:
    $15.40
    Publisher Identifier:
    P-PER
    Discount Code:
    A
    Pub Discount:
    65
    Imprint:
    AEI Press
    Country of Origin:
    United States
    Series:
    AEI Evaluative Studies
  • Overview

    In its efforts to control the use of cocaine, heroin, marijuana, and other illegal drugs, the United States spends about $35 billion per year in public funds. Almost half a million dealers and users are under incarceration. In this book, David Boyum and Peter Reuter provide an assessment of how well this massive investment of tax dollars and government authority is working. Boyum and Reuter show that America’s drug problem is mainly a legacy of the epidemics of heroin, cocaine, and crack use during the 1970s and 1980s, which left us with aging cohorts of criminally active and increasingly sick users. Newer drugs, such as Ecstasy and methamphetamine, perennially threaten to become comparable problems, but so far have not. Using a market framework, the book discusses the nature and effectiveness of efforts to tackle the nation’s drug problems. Drug policy has become increasingly punitive, with the number of drug offenders in jail and prison growing tenfold between 1980 and 2003. Nevertheless, there is strikingly little evidence that tougher law enforcement can materially reduce drug use. By contrast, drug treatment services remain in short supply, even though research indicates that treatment expenditures easily pay for themselves in terms of reduced crime and improved productivity. Boyum and Reuter conclude that America’s drug policy should be reoriented in several ways to be more effective. Enforcement should focus on reducing drug-related problems, such as violence associated with drug markets, rather than on locking up large numbers of low-level dealers. Treatment services for heavy users, particularly methadone and other opiate maintenance therapies, need more money and fewer regulations. And programs that coerce convicted drug addicts to enter treatment and maintain abstinence as a condition of continued freedom should be expanded. The AEI Evaluative Studies series aims to promote greater understanding and continuing review of major activities of the federal government. Each study focuses on a gov